$宝济药业-B(02_老虎社区_美港股上老虎

$宝济药业-B(02659)$ 其核心产品SJ02（晟诺娃）作为中国首款长效重组人卵泡刺激素，已实现商业化，由安科生物独家代理，3月相关商业化工作稳步开展

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":542097706960904,"tweetId":"542097706960904","gmtCreate":1773373639753,"gmtModify":1773373641670,"author":{"id":4203909980173582,"idStr":"4203909980173582","authorId":4203909980173582,"authorIdStr":"4203909980173582","name":"Y2301156","avatar":"https://static.tigerbbs.com/cba88a66df5e28ed78bd3f5925c72e69","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":4,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 其核心产品SJ02（晟诺娃）作为中国首款长效重组人卵泡刺激素，已实现商业化，由安科生物独家代理，3月相关商业化工作稳步开展</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$ </a> 其核心产品SJ02（晟诺娃）作为中国首款长效重组人卵泡刺激素，已实现商业化，由安科生物独家代理，3月相关商业化工作稳步开展</p></body></html>","text":"$宝济药业-B(02659)$ 其核心产品SJ02（晟诺娃）作为中国首款长效重组人卵泡刺激素，已实现商业化，由安科生物独家代理，3月相关商业化工作稳步开展","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/542097706960904","repostId":0,"isVote":1,"tweetType":1,"viewCount":87,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02659"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":131,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}